Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Active Relief Roll-On Product at Pittsburgh World Medical Cannabis Conference & Expo

SAN DIEGO, April 12, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® has released a new topical hemp product, its Active Relief Roll-On, at the 2018 World Medical Cannabis Conference & Expo in Pittsburgh, PA.

The World Medical Cannabis Conference, which takes place April 12-14, is an annual industry event committed to educating people on the many wellness, economic and environmental benefits of cannabis.

HempMeds® Active Relief Roll-On is formulated with natural herbal extracts, menthol and 10 mg of hemp extract. It features a quick dry formula and a light menthol scent. HempMeds® Active Relief Roll-On cooling effects help sooth tired, overworked muscles and address the joint stiffness and discomfort that come with everyday exertion.

“The company is pleased to announce a new topical hemp product, targeted to athletes and active adults, at this international cannabis event,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We hope that it will help provide people with the comforting effects they need to live their best, fullest lives.”

Learn more about HempMeds® Active Relief Roll-On and other exciting CBD hemp oil products at

About HempMeds®

HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC PINK: MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]